Bristol-Myers Squibb Co. said its experimental brivanib drug for liver cancer didn’t improve patient survival better than a placebo.
Onyx Pharmaceuticals Inc. increased the most in nine months after its Nexavar treatment for advanced liver cancer outperformed a potential competitor from Pfizer Inc. in trials.
Bayer AG ’s Nexavar treatment for advanced liver cancer will be tested against a radiotherapy made by Sirtex Medical Ltd. in a final-stage study of patients in the Asia-Pacific region.
The first man on the moon, the first U.S. woman in space and the first black Federal Reserve member were among the notable deaths in 2012.
A radiation treatment that attacks cancer in the liver from the inside is putting Sirtex Medical Ltd. back into the takeover spotlight.
Celsion Corp. plunged the most ever in New York trading after the company announced its experimental treatment for liver cancer failed in a study.
A genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival more than a year, a study found.
Gilead Sciences Inc.’s hepatitis C drug Sovaldi offers a benefit for patients, though the extent to which it prevents liver cancer is unclear, according to Germany’s drug-review panel.